Ventyx Biosciences Ownership | Who Owns Ventyx Biosciences?
Ventyx Biosciences Ownership Summary
Ventyx Biosciences is owned by 6.85% institutional investors, 4.22% insiders, and 88.94% retail investors. Blackrock is the largest institutional shareholder, holding 7.72% of VTYX shares. American Funds SMALLCAP World A is the top mutual fund, with 7.43% of its assets in Ventyx Biosciences shares.
VTYX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ventyx Biosciences | 6.85% | 4.22% | 88.94% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 4.77M | 7.72% | $11.02M |
| Vanguard group | 3.94M | 5.53% | $35.61M |
| Vestal point capital, lp | 2.05M | 2.88% | $6.38M |
| Redmile group | 1.07M | 1.51% | $3.34M |
| Bank of america corp /de/ | 413.13K | 0.67% | $954.34K |
| Two sigma advisers, lp | 315.60K | 0.44% | $981.52K |
| Cubist systematic strategies | 149.50K | 0.24% | $345.35K |
| Nuveen asset management | 168.42K | 0.24% | $368.84K |
| Stempoint capital lp | 167.47K | 0.24% | $520.83K |
| Susquehanna group, llp | 152.64K | 0.22% | $334.27K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Redmile group | 1.07M | 0.32% | $3.34M |
| Vestal point capital, lp | 2.05M | 0.29% | $6.38M |
| Stempoint capital lp | 167.47K | 0.10% | $520.83K |
| Adar1 capital management | 81.60K | 0.02% | $253.78K |
| Nverses capital | 3.70K | 0.01% | $8.55K |
| Prelude capital management | 21.20K | 0.01% | $65.93K |
| Asset dedication | 4.30K | 0.00% | $38.84K |
| Susquehanna fundamental investments | 20.78K | 0.00% | $64.62K |
| Cubist systematic strategies | 149.50K | 0.00% | $345.35K |
| Two sigma advisers, lp | 315.60K | 0.00% | $981.52K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 4.77M | 0.00% | 1.02M |
| Vanguard group | 3.94M | 0.00% | 173.57K |
| Stempoint capital lp | 167.47K | 0.10% | 167.47K |
| Two sigma advisers, lp | 315.60K | 0.00% | 143.20K |
| Bank of america corp /de/ | 413.13K | 0.00% | 109.89K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Affinity asset advisors | - | - | -6.48M |
| Capital investors | - | - | -5.25M |
| Morgan stanley | - | - | -4.29M |
| Farallon capital management | - | - | -3.17M |
| Blackrock funding, inc. /de | - | - | -3.14M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Stempoint capital lp | 167.47K | 0.10% | 167.47K | $520.83K |
Sold Out
| Holder | Change |
|---|---|
| Dauntless investment group | -1.00 |
| Ifp advisors | -5.00 |
| Nelson, van denburg & campbell wealth management group | -9.00 |
| Srs capital advisors | -15.00 |
| Eversource wealth advisors | -40.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 26 | -77.19% | 4,882,073 | -88.87% | 6 | 0.18% | 11 | -79.25% | 9 | -74.29% |
| Sep 30, 2025 | 29 | -73.64% | 6,121,464 | -84.99% | 8 | 0.26% | 9 | -85.25% | 10 | -71.43% |
| Jun 30, 2025 | 116 | -3.33% | 44,424,800 | 0.02% | 62 | 1.60% | 60 | 9.09% | 40 | 14.29% |
| Mar 31, 2025 | 9 | -92.91% | 8,136,748 | -85.06% | 11 | 0.19% | 4 | -94.20% | 3 | -89.66% |
| Dec 31, 2024 | 121 | 1.68% | 53,151,208 | 1.28% | 75 | 1.36% | 65 | 8.33% | 28 | -9.68% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 5.25M | 7.43% | 2.89M |
| Vanguard Total Stock Mkt Idx Inv | 2.01M | 2.81% | - |
| BlackRock Event Driven Equity Instl | 1.03M | 1.44% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 699.62K | 0.97% | 2.17K |
| Fidelity Small Cap Index | 621.71K | 0.87% | -23.02K |
| BlackRock Health Sciences Opps Inv A | 590.65K | 0.82% | -4.42K |
| Arbitrage R | 575.00K | 0.80% | 575.00K |
| iShares Russell 2000 Value ETF | 536.88K | 0.75% | - |
| iShares Biotechnology ETF | 481.33K | 0.67% | - |
| Delaware Healthcare I | 430.00K | 0.61% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 18, 2025 | Mohan Raju | CEO AND PRESIDENT | Sell | $365.46K |
| Dec 18, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | $97.84K |
| Apr 02, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | $2.02K |
| Dec 27, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | $49.84K |
| Dec 23, 2024 | Gujrathi Sheila | - | Buy | $300.57K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | 2 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | - |
| 2024 Q4 | 3 | 2 |
VTYX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools